AT GENETICURE, WE ARE SHAPING THE FUTURE OF PRESCRIPTION MEDICINE.
Now, for the first time, our CLIA-certified laboratory can perform a test to quickly and accurately guide your ideal hypertension drug therapy - all with a simple and non-invasive cheek swab.
Now, for the first time, our CLIA-certified laboratory can perform a test to quickly and accurately guide your ideal hypertension drug therapy - all with a simple and non-invasive cheek swab.
Location: United States, Minnesota, Minnetonka
Employees: 11-50
Phone: +1 800-362-8109
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Plug and P... | plugandpla... |
| - | Wireframe ... | wireframev... |
Mentions in press and media 2
| Date | Title | Description |
| 21.02.2022 | Geneticure Announces Technology to Drive an Estimated 250% Increase in Renal Denervation Adoption Using Genetic Screening to Rule Out Non-responders | I have recognized the promise and potential of renal denervation for patients through my experience and believe that it’s benefit could be further strengthened by a test that better predicts responders vs non-responders. ROCHESTER, Minn. (P... |
| 12.09.2017 | 23andMe raises $250M led by Sequoia Capital | Others in the genomics space that have raised funding include Counsyl, Veritas and Sophia It's been 17 years since the Human Genome Project, led by Dr. Craig Venter, announced the mapping of the human genome, a breakthrough in science that ... |